Glucose Braun

Glucose Braun is an intravenous glucose solution supplied in a liquid form, containing the active ingredient glucose. It is manufactured for the European market and intended for use in clinical settings where rapid delivery of carbohydrate energy is required. The product is packaged in containers for infusion and administered by healthcare professionals under medical supervision. The formulation complies with EU pharmacopeial standards and is compatible with standard infusion devices.

Glucose Braun is employed in clinical settings to supply immediate carbohydrate calories and help maintain fluid balance. Typical applications include:

- Treatment of acute hypoglycemia when oral intake is not possible - Peri‑operative fluid replacement to support energy needs - Nutritional support for patients receiving enteral or parenteral therapy - Dilution medium for compatible intravenous medications - Adjunct to electrolyte solutions for balanced resuscitation

Glucose Braun may be associated with a range of adverse reactions, most of which are related to the intravenous administration of a carbohydrate solution.

Common: - Mild hyperglycemia or transient rise in blood glucose - Local irritation at the infusion site - Nausea or mild gastrointestinal discomfort - Headache or dizziness during rapid infusion - Electrolyte shifts such as mild hyponatremia - Transient increase in serum osmolality

Serious: - Severe hyperglycemia leading to osmotic diuresis - Allergic or anaphylactoid reaction (rash, urticaria, bronchospasm) - Volume overload or pulmonary edema in susceptible patients - Metabolic acidosis in cases of massive infusion - Hyperosmolar hyperglycemic state in diabetic individuals - Sepsis or infection related to contaminated infusion equipment

When using Glucose Braun, healthcare providers should observe several safety considerations to reduce risk:

- Verify patient blood‑glucose level before and during infusion, especially in diabetic or critically ill patients - Adjust infusion rate in patients with impaired renal or cardiac function to avoid fluid overload - Use aseptic technique to prevent contamination of the solution - Monitor electrolytes, particularly sodium and potassium, as glucose infusion can affect their balance - Avoid rapid bolus administration unless specifically indicated - Document the concentration and total volume administered in the patient record - Ensure compatibility with other intravenous drugs before co‑administration

Glucose Braun can interact with other medications or clinical conditions, requiring careful assessment.

Avoid: - Co‑administration with insulin or other hypoglycemic agents without adjusting doses, as this may precipitate severe hypoglycemia - Mixing with calcium‑containing solutions that may precipitate insoluble salts - Use in patients with known severe hyperglycemia or uncontrolled diabetes without medical supervision

Use with caution: - Concurrent administration of diuretics that may alter fluid and electrolyte status - Beta‑blockers, which can mask symptoms of hypoglycemia - Corticosteroids, which can increase blood‑glucose levels - Parenteral nutrition regimens that already contain carbohydrate calories - Medications that affect renal function, requiring close monitoring of fluid balance